XFOR - X4 Pharmaceuticals, Inc

QQQ $ 618.13 $ 2.13 (0.34 %)

DIA $ 472.71 $ 2.84 (0.6 %)

SPY $ 678.14 $ 1.66 (0.25 %)

TLT $ 91.53 $ -0.04 (-0.04 %)

GLD $ 378.05 $ -0.48 (-0.13 %)

Previous Close

$ 3.09

Open

$ 3.40

Bid

$ 3.81 x 1,465

Ask

$ 3.82 x 400

Day's Range

$ 3.35 - $ 4.54

52 Week Range

$ 1.35 - $ 26.83

Volume

270,273

Average Volume

Market Cap

35.25M

Beta (5Y Monthly)

$ 1.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2025	06-30-2025	10-Q
2	05-01-2025	03-31-2025	10-Q
3	03-25-2025	12-31-2024	10-K
4	11-13-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-07-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-04-2023	03-31-2023	10-Q
11	03-21-2023	12-31-2022	10-K
12	11-03-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-17-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-03-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	03-19-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-04-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-12-2020	12-31-2019	10-K
24	11-07-2019	09-30-2019	10-Q
25	08-07-2019	06-30-2019	10-Q
26	05-15-2019	03-31-2019	10-Q
27	03-11-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-13-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-09-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

X4 Pharmaceuticals Prices $135M Public Off...
10/24/2025 06:25:31

And, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 700,000 shares of its common stock at ...

X4 Pharmaceuticals Launches Of An Underwri...
10/23/2025 20:05:38

X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with ...

X4 Pharmaceuticals Announces Strategic Res...
09/17/2025 11:12:37

Organizational restructuring including a 50% reduction in workforce that is anticipated to result in annualized cost savings of...

Stifel Maintains Buy on X4 Pharmaceuticals...
08/29/2025 13:13:31

Stifel analyst Stephen Willey maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the price target from $30 to $9.

12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 17:06:05

12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

12 Health Care Stocks Moving In Wednesday'...
08/13/2025 12:08:29

HC Wainwright & Co. Maintains Buy on X4 Ph...
08/13/2025 11:55:47

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the ...

Trading Halt: Halt status updated at 7:25:...
08/13/2025 11:25:04

Trading Halt: Halted at 3:37:44 p.m. ET - ...
08/12/2025 19:37:49

12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

X4 Pharmaceuticals Secures $60M Private Pl...
08/12/2025 11:21:23

X4 Pharmaceuticals' President And CEO Paul...
08/12/2025 11:16:47

X4 Pharmaceuticals Announced Private Place...
08/12/2025 11:14:15

$60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise AssociatesNewly appointed b...

12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

12 Health Care Stocks Moving In Thursday's...
07/24/2025 21:06:08

12 Health Care Stocks Moving In Thursday's...
07/24/2025 17:06:06

X4 Pharmaceuticals Enters Purchase Agreeme...
06/23/2025 20:41:12

https://www.sec.gov/ix?doc=/Archives/edgar/data/1501697/000162828025032627/xfor-20250623.htm

X4 Pharmaceuticals Highlights Presentation...
06/16/2025 12:05:18